...
首页> 外文期刊>BioMed research international >Biomaterials in Cardiovascular Research: Applications and Clinical Implications
【24h】

Biomaterials in Cardiovascular Research: Applications and Clinical Implications

机译:心血管研究中的生物材料:应用和临床意义

获取原文

摘要

Cardiovascular biomaterials (CB) dominate the category of biomaterials based on the demand and investments in this field. This review article classifies the CB into three major classes, namely, metals, polymers, and biological materials and collates the information about the CB. Blood compatibility is one of the major criteria which limit the use of biomaterials for cardiovascular application. Several key players are associated with blood compatibility and they are discussed in this paper. To enhance the compatibility of the CB, several surface modification strategies were in use currently. Some recent applications of surface modification technology on the materials for cardiovascular devices were also discussed for better understanding. Finally, the current trend of the CB, endothelization of the cardiac implants and utilization of induced human pluripotent stem cells (ihPSCs), is also presented in this review. The field of CB is growing constantly and many new investigators and researchers are developing interest in this domain. This review will serve as a one stop arrangement to quickly grasp the basic research in the field of CB.
机译:基于该领域的需求和投资,心血管生物材料(CB)占据了生物材料的类别。这篇评论文章将认证机构分为三大类,即金属,聚合物和生物材料,并整理了有关认证机构的信息。血液相容性是限制将生物材料用于心血管应用的主要标准之一。有几个关键因素与血液相容性有关,本文将对其进行讨论。为了增强CB的兼容性,目前正在使用几种表面改性策略。为了更好地理解,还讨论了表面修饰技术在心血管设备材料上的一些最新应用。最后,本综述还介绍了CB的当前趋势,心脏植入物的内皮化和诱导人多能干细胞(ihPSC)的利用。认证机构的领域在不断发展,许多新的研究人员和研究人员正在对该领域产生兴趣。这篇评论将作为一站式安排,以快速掌握CB领域的基础研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号